VANCOUVER, BRITISH COLUMBIA--(Marketwired - April 20, 2017) - Affinor Growers (CSE:AFI)(CSE:AFI.CN)(OTCQB:RSSFF)(FRANKFURT:1AF) ("Affinor" or the "Corporation) is pleased to announce it has sold a vertical farming system for growing medical cannabis in British Columbia, Canada. Affinor has signed a non-exclusive license and purchase agreement with a private third party to buy an automated vertical growing tower specifically for medical cannabis.

The four level tower will allow the purchaser to grow medical cannabis on behalf of a patient through a recently applied medical license. Under the agreement, Affinor will continue to receive growing information and replication data from the tower's growing results. The tower will also be used to further develop and test the technology with different cannabis strains and LED lighting which will demonstrate new capabilities for low cost, high quality production of personal medical cannabis.

As a seller of agriculture growing systems, this is a starting point to introduce Affinor's technology in the cannabis market and further prove it is a viable technology for growing cost effective medical cannabis. Affinor is one of a few companies now actively testing and selling cannabis vertical growing systems through its licensees.

Mission, BC, medical cannabis test update

The medical cannabis-growing test in Mission, BC is now into the 5^th week of the trial and is expected that the plants will be fully grown in 3 to 4 weeks. To date, the plants have begun to flower and the test is on schedule.

About Affinor Growers Inc.

Affinor Growers is a publicly traded company on the Canadian Securities Exchange under the symbol ("AFI"). Affinor is focused on growing high quality crops such as romaine lettuce, spinach, and strawberries using its vertical farming techniques. Affinor is committed to becoming a pre-eminent supplier and grower, using exclusive vertical farming techniques.

On Behalf of the Board of Directors, AFFINOR GROWERS INC.

Jarrett Malnarick, President & CEO

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

FORWARD LOOKING INFORMATION

This News Release contains forward-looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", "may", "will", "project", "should", "believe" and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this News Release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company's disclosure documents which can be found under the Company's profile on www.sedar.com. This News Release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.